D-Amino acid oxidase activity and expression are increased in schizophrenia
Open Access
- 18 June 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Psychiatry
- Vol. 13 (7), 658-660
- https://doi.org/10.1038/mp.2008.47
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Expression of D-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophreniaSchizophrenia Research, 2008
- In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic propertiesEuropean Neuropsychopharmacology, 2008
- Glycine Transport Inhibitors and the Treatment of SchizophreniaBiological Psychiatry, 2008
- Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophreniaEuropean Neuropsychopharmacology, 2007
- d‐Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophreniaEuropean Journal of Neuroscience, 2007
- A CSF and postmortem brain study of d-serine metabolic parameters in schizophreniaSchizophrenia Research, 2007
- Preliminary evidence for a link between schizophrenia and NMDA–glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1)Brain Research, 2006
- Genetic and physiological data implicating the new human gene G72 and the gene for d -amino acid oxidase in schizophreniaProceedings of the National Academy of Sciences of the United States of America, 2002
- Glutamatergic Mechanisms in SchizophreniaAnnual Review of Pharmacology and Toxicology, 2002
- d -Serine is an endogenous ligand for the glycine site of the N -methyl- d -aspartate receptorProceedings of the National Academy of Sciences of the United States of America, 2000